Cargando…
Local immune microenvironment of skin may play an important role in the development of pretibial myxedema
Pretibial myxedema (PTM), characterized by the accumulation of glycosaminoglycans in dermis is an autoimmune skin disorder, which is almost always associated with Graves’ disease (GD). Although fibroblast stimulated by thyroid‐stimulating hormone receptor (TSHR) antibody, cytokines and growth factor...
Autores principales: | Chen, Xiaoying, Dong, Jiaoyun, Zhang, Li, Zhao, Xiaoqing, Shi, Ruofei, Pan, Meng, Zheng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597019/ https://www.ncbi.nlm.nih.gov/pubmed/34047397 http://dx.doi.org/10.1111/exd.14402 |
Ejemplares similares
-
Teprotumumab for Treatment of Pretibial Myxedema
por: Reyes, Michelangelo P, et al.
Publicado: (2023) -
Pretibial Myxedema Presenting as Severe Elephantiasis
por: Lee, Jae-Hoon, et al.
Publicado: (2018) -
Treatment of pretibial myxedema with intralesional immunomodulating therapy
por: Ren, Ziwei, et al.
Publicado: (2017) -
Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018) -
Elephantiasic Pretibial Myxedema with Involvement of the Buttocks and Face
por: Wang, Ya-Nan, et al.
Publicado: (2017)